Prevalence of Thrombocytopenia in People with Malaria

Abstract

Background: One of the most common issues that causes high morbidity and mortality worldwide is malaria. Malaria is a vector-borne disease. Malaria’s transmission is done by female anopheles. The World Health Organization reported that 7.8 million people every year die because of malaria. Every year, more than 225 million people globally are affected due to malaria. Pakistan has a high prevalence of malaria, a major public health concern. Malaria is diagnosed by examining blood smears stained with Giemsa under a microscope. Malaria caused by the Plasmodium vivax parasite is more common and affects a broader population than Plasmodium falciparum malaria.Objective: To determine the prevalence of thrombocytopenia in malaria patients at a tertiary care hospital.Study design: A cross-sectional studyPlace and Duration This study was conducted in People's University of Medical and Health Sciences for Women Nawabshah from May 2022 to May 2023 Methodology: A total of 200 participants were selected for this research through the WHO sample size calculator. All the patients included in this research were diagnosed with malaria. The ages of all of the participants ranged from 18 to 60 years old. Every participant’s medical history and information related to demographics was collected through a pre-designed proforma. People who tested positive for malaria underwent clinical examinations.Results: There were a total of 200 peoples  enrolled in this research. A total of 110 males and 90 females were included in this research. The average age calculated was 26 years. The majority of the patients were in the age range of 18 to 30 years. The frequency of thrombocytopenia against malaria was 180 (90%). Conclusion: In conclusion, thrombocytopenia is the most prevalent in those people who are diagnosed with malaria.